Extremities remain a popular growth market within orthopedics and med-tech, and that has kept Wright Medical Group (WMGI)
a pretty popular stock. With mostly solid fourth quarter results and
guidance, and growing expectations for more M&A in the space, I
don't think Wall Street is in a hurry to jump off this name just yet.
The valuation doesn't really look a huge bargain, though, so investors
buying into Wright Medical should realize that any interruptions in
growth could bring swift and severe punishment for the market.
Follow the link to read more:
Wright Medical Has The Right Stuff, But Isn't Cheap
No comments:
Post a Comment